These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8485059)

  • 1. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.
    Spielberger RT; Dickstein JI; Le Beau MM; Larson RA; Daly KM; Vardiman JW; Golomb HM
    Br J Haematol; 1993 Mar; 83(3):519-20. PubMed ID: 8485059
    [No Abstract]   [Full Text] [Related]  

  • 2. Considerations on the pathogenesis of acute myeloid leukaemia in a splenectomized hairy cell leukaemia patient treated with interferon-alpha.
    Demeter J; Turbucz P; Lehoczky D; Porzsolt F
    Br J Haematol; 1994 Jan; 86(1):236. PubMed ID: 8011543
    [No Abstract]   [Full Text] [Related]  

  • 3. Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia.
    Guerci AP; Guerci B; Lévy-Marchal C; Ongagna J; Ziegler O; Candiloros H; Guerci O; Drouin P
    Lancet; 1994 May; 343(8906):1167-8. PubMed ID: 7910261
    [No Abstract]   [Full Text] [Related]  

  • 4. Regression of diffuse osteosclerosis in hairy cell leukaemia after treatment with interferon.
    Verhoef GE; De Wolf-Peeters C; Zachee P; Boogaerts MA
    Br J Haematol; 1990 Sep; 76(1):150-1. PubMed ID: 2223637
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical evaluation of hairy cell leukemia.
    Demeter J; Porzsolt F
    Blood; 1992 Apr; 79(8):2171-3. PubMed ID: 1510754
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
    Moormeier JA; Ratain MJ; Westbrook CA; Vardiman JW; Daly KM; Golomb HM
    J Natl Cancer Inst; 1989 Aug; 81(15):1172-4. PubMed ID: 2746669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocytosis in hairy cell leukaemia following therapy with interferon alpha.
    Steis RG; VanderMolen LA; Lawrence J; Sing G; Ruscetti F; Smith JW; Urba WJ; Clark J; Longo DL
    Br J Haematol; 1990 May; 75(1):133-5. PubMed ID: 2375913
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible cardiomyopathy in a patient with hairy cell leukaemia.
    Sucak GT; Haznedar R; Yalçin R
    Postgrad Med J; 1998 May; 74(871):313-4. PubMed ID: 9713625
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia.
    Stratta P; Canavese C; Dogliani M; Thea A; Degani G; Mairone L; Vercellone A
    Ren Fail; 1993; 15(4):559-61. PubMed ID: 8210571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleural involvement in hairy cell leukemia response to recombinant interferon-alpha.
    Raffi F; Magadur G; Fiche M; Merrien D; Barrier JH; Grolleau JY
    Chest; 1990 Dec; 98(6):1544. PubMed ID: 2245718
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha interferon treatment of patients with hairy-cell leukaemia.
    Hagberg H; Alm G; Björkholm M; Glimelius B; Killander A; Simonsson B; Sundström C; Ahre A
    Scand J Haematol; 1985 Jul; 35(1):66-70. PubMed ID: 4048862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular confronting cisternae in hairy cells following interferon therapy.
    Rinderknecht BP; Litzistorf Y; Hurwitz N; Sauter G; Gudat F; Denz MD; Ludwig C
    Ann Oncol; 1990 Nov; 1(6):451. PubMed ID: 2083192
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon alpha in the treatment of hairy cell leukemia.
    Castaigne S; Sigaux F; Cantell K; Falcoff E; Boiron M; Flandrin G; Degos L
    Cancer; 1986 Apr; 57(8 Suppl):1681-4. PubMed ID: 3948138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation.
    Sgarabotto D; Zerbinati P; Vianello F; Valeri P; Girolami A; Dazzi F
    Haematologica; 1992; 77(4):367-8. PubMed ID: 1427450
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment of hairy cell leukemia with interferon alfa-2b.
    Hofmann V; Frey B
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():7-13. PubMed ID: 3342418
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of interferon-alpha and granulocyte colony-stimulating factor in hairy cell leukaemia with aplastic marrow.
    Osterholz J; Wohlleber M; Kahnt C; Schumacher K
    Eur J Haematol; 1995 Aug; 55(2):140-2. PubMed ID: 7543058
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
    Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
    Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of bone marrow changes during the treatment of hairy cell leukemia with interferon alpha.
    Flandrin G; Sigaux F; Castaigne S; Degos L
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():17-22. PubMed ID: 3833326
    [No Abstract]   [Full Text] [Related]  

  • 20. Three years' continuous low-dose interferon-alpha treatment of hairy-cell leukemia: evaluation of response and maintenance dose.
    Goldmann B; Sonnen R; Kuse R
    Eur J Haematol; 1993 Sep; 51(3):177-8. PubMed ID: 8405334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.